Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study
Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
This study seeks to confirm a demonstrated treatment effect of intepirdine (RVT-101) as an
adjunctive therapy to donepezil for the treatment of subjects with Alzheimer's disease.